Western Diagnostic Pathology Revenue and Competitors

AU

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Western Diagnostic Pathology's estimated annual revenue is currently $139.7M per year.(i)
  • Western Diagnostic Pathology's estimated revenue per employee is $337,500

Employee Data

  • Western Diagnostic Pathology has 414 Employees.(i)
  • Western Diagnostic Pathology grew their employee count by 5% last year.

Western Diagnostic Pathology's People

NameTitleEmail/Phone
1
Medical DirectorReveal Email/Phone
2
Medical Liaison OfficerReveal Email/Phone
3
Quality ManagerReveal Email/Phone
4
Medical Laboratory ScientistReveal Email/Phone
5
Medical ScientistReveal Email/Phone
6
Medical Laboratory ScientistReveal Email/Phone
7
PhlebotomistReveal Email/Phone
8
Medical Laboratory ScientistReveal Email/Phone
9
PhlebotomistReveal Email/Phone
10
Medical ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M34N/AN/AN/A
#2
$26.2M97N/AN/AN/A
#3
$71.6M2418%N/AN/A
#4
$34M1261%N/AN/A
#5
$47.8M161-7%N/AN/A
#6
$65.9M2224%N/AN/A
#7
$30M111-12%N/AN/A
#8
$295.6M7828%N/AN/A
#9
$24M8919%N/AN/A
#10
$34.6M12810%N/AN/A
Add Company

What Is Western Diagnostic Pathology?

At Western Diagnostic Pathology, weâ??re committed to supporting practitioners by delivering timely, accurate, and high quality diagnostic results. We know that patients all across Western Australia and the Northern Territory rely on us to collect, analyse, and report results â?? and itâ??s a responsibility we take very seriously.\n\nWe have a team of more than 900 people who work year round to deliver results. Our team includes collectors, couriers, laboratory assistants, scientists, and pathologists, all supported by operations, logistics, administration, data entry, and call centre teams.\n\nWhile our core laboratory is located in Myaree, we have 10 laboratories across WAâ?? many based in hospitals â?? and two in the NT to ensure we can get results back to doctors as soon as possible. We also have more than 200 collection centres for patients to visit at their convenience. In addition to this, we provide a number of Workplace Health & Safety testing for commercial clients.\n\nWestern Diagnostic Pathology (WDP) was founded in 1972 by Dr D.J. McCully and four other pathologist partners from the Sir Charles Gardner Hospital.\n\nâ??Western Pathologyâ?? as it was then known, expanded rapidly and quickly became recognised as the pre-eminent Western Australian pathology provider. In 1986, Markalinga, the developer and owner of Perth and Sydneyâ??s premier tertiary private hospitals of the time, purchased the shares in the operating company of the pathology service, with Dr McCully and the other senior pathologists continuing to retain ownership of the pathology partnership.\n\nSince that date, the practice has experienced a number of different controlling shareholders and eventually was acquired in 2008 by Healius Ltd and became part of the Specialist Diagnostic Services network of pathology practices.

keywords:N/A

N/A

Total Funding

414

Number of Employees

$139.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Western Diagnostic Pathology News

2022-04-20 - Despite losing federal money, California is still testing ...

Roche said it anticipates sales for its COVID-19 diagnostics and medicines ... to develop artificial intelligence programs for its digital pathology suite,...

2022-04-17 - Bernard J. Panner Obituary - Rochester Democrat And ...

He studied chemistry and then medicine at Western Reserve ... practice renal pathology at Strong – where he was a pioneer in the diagnostic...

2022-04-06 - Mt Hawthorn residents call for end to Western Diagnostic Pathology COVID drive-through testing clinic

... are begging their local council to stop Western Diagnostic Pathology from operating its Mt Hawthorn COVID testing drive-through clinic.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$103.9M414N/AN/A
#2
$15M414N/AN/A
#3
$127.3M4144%N/A
#4
$108.7M4143%N/A
#5
$93.2M4145%N/A